PATENT CLAIM ANALYSIS

Application Number: 16223009
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "131100"]

Abstract:
Provided are anti-CD47 monoclonal antibodies (anti-CD47 mAbs) with distinct functional profiles as described herein, methods to generate anti-CD47 mAbs, and to methods of using these anti-CD47 mAbs as therapeutics for the prevention and treatment of solid and hematological cancers, ischemia-reperfusion injury, cardiovascular diseases, autoimmune diseases, inflammatory diseases or as diagnostics for determining the level of CD47 in tissue samples.

Claim (Index 3):
The monoclonal antibody, or antigen binding fragment thereof, of  claim 2 , wherein the monoclonal antibody, or antigen binding fragment thereof, further exhibits pH-dependent binding to human CD47 present on a cell.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.47826
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15820054', '15473206', '15712010', '15711971', '14700105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7966694999820758
- 35 USC 102 Novelty (BERT): 0.6368076146625054
- Combined Prediction Score: 0.7806833114501188
- Mean Citation Score: 504.45688200000006
- Max Citation Score: 732.706
- Similarity Product: 536.1730840141773

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test